This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Tel Aviv University. Active years: 2020-2021.
Company Filing History:
Years Active: 2020-2021
Title: Julia Leitman: Innovator in Protein Aggregation Research
Introduction
Julia Leitman is a prominent inventor based in Petach-Tikva, Israel. She has made significant contributions to the field of biomedical research, particularly in the area of protein aggregation and its associated diseases. With a total of 2 patents, her work focuses on developing innovative solutions for treating conditions linked to aggregation-prone proteins.
Latest Patents
Leitman's latest patents include groundbreaking research on PERK inhibitors and their uses in treating diseases associated with aggregation-prone proteins. The compounds represented by Formula I are disclosed in her patents, wherein R, Ra, and R are defined. These patents further elaborate on the uses and methods for utilizing these compounds to inhibit the activity of PERK. This inhibition is particularly beneficial in treating diseases or disorders associated with aggregation-prone proteins, including Huntington's disease.
Career Highlights
Julia Leitman is affiliated with Tel Aviv University, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community for its potential impact on treating serious health conditions.
Collaborations
Leitman collaborates with esteemed colleagues, including Daniel Offen and Gerardo Zelmar Lederkremer. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Julia Leitman is a dedicated inventor whose work in protein aggregation research holds promise for developing effective treatments for related diseases. Her contributions to science and innovation continue to pave the way for future advancements in biomedical research.